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MORADY, F., ET AL.: Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-
Parkinson-White syndrome. AtriaJ jibriJlation was induced during an electrophysiology study in 10 patients
with the Wolff-Parkinson-White (WPW) syndrome, after determination 0/baseline properties of the accessory
atrioventricular (AV) connection; intravenous propranoIoJ (0.2 mg/kg) was then administered. Atrial fi-
brillation terminated during the drug in/usion in three patients, aliowing determination o/propranoloi's
effects on conduction and re/ra c tor in ess during sinus rhythm, be/ore atrial jibriJiation was reinduced. In
these three patients propranoioi had no effect on refractoriness or conduction properties of the accessory
AV connection during sinus rhythm. The mean ventricular rate during atrial jibrillation was slowed by
i5-56 beats/min in six patients, had no effect on the mean rate in three patients, and markedly increased
the ventricular rate (203 to 267 beats/min} in one patient. In this patient, 54% o/QRS complexes during
atriaJ fibriJJation were narrow, compared to 0-25% in the other patients. Propranoioi reduced the percentage
o/QRS complexes (hat were narrow from 13 ± 16% to 1 ± 2% (mean ± standard deviation, p < 0.05). We
concJude that propranoJoI may slow (he ventricuJar rate during atriaJ /ibrilJation in some patients with
the WPW syndrome, probabJy by bJocJcing the effects of adrenergic activation. However, propranoIoJ should
not be used in patients with the WPW syndrome who have atriaJ fibriiJation, if most QRS compJexes during
atrial fibrillation are preexcited. When a Jarge percentage ofQHS complexes are narrow, propranoJoJ may
increase the ventricuJar rate, probabJy by eJiminating conceaJed retrograde conduction in the accessory
AV connection. [PACE, Vol. 10, May, 1987]
Woiff-ParJtinson-White syndrome, atriaJ fibriJJation, propranoioi
Introduction
Factors that influence ventricular rate during
atrial fibrillation in the Wolff-Parkinson-White
[WPW] syndrome include the refractory periods
of the accessory atrioventricular (AV) connection
and the AV node, concealed conduction in the ac-
cessory AV connection and the AV node, the ven-
tricular refractory period, and the degree of ad-
renergic activation.^ Although propranolol has
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been shown to have no effects on accessory AV
connection properties,^ its effect on the ventricular
rate during atrial fibrillation in patients with the
WPW syndrome has not been studied. By slowing
conduction through the AV node and eliminating
concealed retrograde conduction in the accessory
AV connection, beta blockade could potentially
increase the ventricular rate during atrial fibril-
lation. On the other hand, blockade of the effects
of adrenergic activation on the accessory AV con-
nection during atrial fibrillation might slow the
ventricular rate.
The purpose of this study was to assess tbe
effect of propranolol on ventricular rate during
atrial fibrillation in patients with the WPW syn-
drome.
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Methods
The subjects in this study consisted of 10 pa-
tients with the WPW syndrome who underwent
an eiectrophysioiogy study before undergoing
surgical or transcatheter accessory pathway ahla-
tion. There were eight men and two women, with
a mean age of 36 ± 14 years (± one standard de-
viation). All patients had a history of recurrent
orthodromic reciprocating tachycardia and five
also had a history of atrial fibrillation, but no pa-
tient had a history of a cardiac arrest.
The eiectrophysioiogy studies were per-
formed in the fasting, unsedated state after in-
formed consent was obtained, and at least five half-
lives after discontinuation of all antiarrhythmic
drugs. Electrode catheters were inserted into the
femoral and subclavian veins and positioned in
the right atrium, across the tricuspid valve for re-
cording the His bundle electrogram, in the right
ventricle and in the coronary sinus. The intracar-
diac electrograms and leads Vj, I, and III were dis-
played on an oscilloscope and recorded on a Min-
gograph* 7 recorder. Pacing was performed with
a programmable stimulator** at twice the diastohc
threshold and with stimuli of 2 ms in duration.
Refractory periods were determined by the
extrastimulus technique using a basic drive cycle
length of 500 ms. In two patients, determination
of the anterograde effective refractory period of
the accessory AV connection was limited by atrial
refractoriness; in these patients, the accessory AV
connection effective refractory period was desig-
nated as being less than the atrial functional re-
fractory period.
After determination of baseline accessory AV
connection properties, induction of orthodromic
reciprocating tachycardia, and mapping ofthe ac-
cessory AV connection, atrial fibrillation was in-
duced by right atrial pacing at cycle lengths he-
tween 150 and 50 ms. After five minutes of atrial
fibrillation, a one-minute recording was obtained.
A 0.2 mg/kg dose of propranolol was then admin-
istered intravenously at a rate of 1 mg/min. The
blood pressure was measured with an arm cuff
every one to two minutes during the infusion. Five
minutes after completion of the drug infusion, an-
' Siemens-Elema AB, Solna, Sweden.
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other one-minute recording of atrial fibrillation
was obtained. In three patients who reverted to
sinus rhythm during the drug infusion, accessory
AV connection properties were determined after
the infusion was completed, before atrial fibrilla-
tion was reinduced. Seven patients remained in
atrial fibrillation after administration of the pro-
pranolol, and they were then given 300-1,000 mg
of procainamide to convert the atrial fibrillation
to sinus rhythm. Procainamide was administered
in order to avoid the need for general anesthesia
and direct current countershock. In these patients,
the effects of propranolol on accessory AV con-
nection conduction and refractoriness could not
be determined. In one patient (#5), the propranolol
infusion was discontinued prematurely (after the
administration of 5 mg) and procainamide was ad-
ministered because of a marked acceleration in
the ventricular rate.
The mean cycle length, the shortest cycle
length between preexcited QRS complexes, the
shortest cycle length between narrow (^0.08 ms)
QRS complexes, and the percentage of QRS com-
plexes that were narrow were all determined from
a one-minute recording of atrial fihrillation hefore
and after the administration of propranolol. Sta-
tistical analyses were performed with either a
paired or unpaired Student's t test. P values < 0.05
were considered significant.
Results
Baseline Accessory AV Connection
Characteristics
The accessory AV connection was located in
the left free wall in six patients and in the posterior
septum in four patients. The shortest atrial pacing
cycle length associated with 1:1 conduction
through the accessory AV connection was 278 ± 43
ms (range 210-350 ms). The mean anterograde re-
fractory period ofthe accessory AV connection was
264 ± 27 ms (range < 220-290 ms).
Effects of Propranolol on Atrial
Fibrillation (Table I)
The mean dose of propranolol administered
was 13 ± 4 mg. Propranolol was associated with a
5-10 mmHg drop in blood pressure in each patient.
The mean ventricular rate during atrial fibrillation





























































































































Abbreviations: bpm = beats/minute; SRR = shortest RR interval.
among the 10 patients was not significantly differ-
ent after propranolol (165 ± 39 beats/min) as com-
pared to baseline (178 ± 20 beats/min; p > 0.05).
The individual responses of the ventricular
rates to propranolol are shown in Figure 1. The
ventricular rate during atrial fibrillation increased
markedly in one patient, remained within 10
beats/min of the baseline ventricular rate in three
patients, and decreased by 15-56 beats/min in the
remaining six patients.
The shortest R-R interval between preexcited
QRS complexes after propranolol (254 ± 44 ms]
was significantly longer than in the baseline state
(230 ± 42 ms; p < 0.05). The shortest R-R interval
between narrow QRS complexes was 353 ± 63 ms
in the baseline state. After propranolol, only one
patient had two consecutive narrow QRS com-
plexes and the R-R interval between the narrow
QRS complexes was 480 ms, The percentage of
QRS complexes that were narrow after propranolol
(1 ± 2%) was significantly lower than in the base-
line state (13 ± 16%; p < 0.05).
Comparing the six patients in whom pro-
pranolol slowed the ventricular rate during atrial
fibrillation by >15 beats/min with the other four
patients, there were no significant differences in
the baseline mean cycle length during atrial fi-
brillation, the shortest R-R interval between
preexcited QRS complexes, the percentage of QRS
complexes that were narrow, or the anterograde
refractory period of the accessory AV connection.
The one patient (#5) who had a marked in-
crease in ventricular rate during atrial fibrillation
after 5 mg of propranolol had, in the baseline state,
the shortest minimum R-R interval between
preexcited and narrow QRS complexes of all 10
patients, and the highest percentage of narrow QRS
complexes (54%).
Effects of Propranolol on Accessory AV
Connection Properties
In patients #3, 4, and 10, accessory AV con-
nection conduction and refractoriness could be
measured before and after propranolol. The short-
est atrial pacing cycle length associated with 1:1
conduction through the accessory AV connection
(290 ± 26 msj was unchanged after propranolol
(280 ± 10 ms), as was the anterograde effective
refractory period of the accessory AV connection
(277 + 12 ms baseline vs. 273 ± 6 ms after pro-
pranolol).
Discussion
This study demonstrates that there is a het-
erogeneous response when intravenous propran-
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Figure 1. The effect of propranolal on ventricular rate during atrial fibrillation in patients with
the Woi^-Parkinson-White syndrome. Shown are (he mean ± standard deviation and the individual
ventricular rates be/ore and after propranolo]. Abbreviation; NS = not significant.
olol is administered during atrial fibrillation in pa-
tients who have the WPW syndrome. Although
the average ventricular rate during atrial fibril-
lation usually is decreased by beta blockade, in
some patients the average ventricular rate may
remain unchanged or may increase markedly.
Despite the fact that propranolol resulted in
a lengthening of the shortest R-R interval between
preexcited QRS complexes and in several patients
slowed the mean ventricular rate during atrial fi-
hrillation, no direct effect of propranolol on ac-
cessory AV connection properties could be dem-
onstrated during sinus rhythm. Although acces-
sory AV connection properties were determined
before and after propranolol in only three patients
in this study, Denes et al., in a much larger series
of 18 patients, also demonstrated that propranolol
has no effects on accessory AV connection con-
duction or refractoriness during sinus rhythm.^ A
possible explanation for these apparently incon-
sistent observations is that anxiety and/or hypo-
tension during atrial fibrillation results in adren-
ergic activation which in turn results in a short-
ening of accessory AV connection refractoriness
and acceleration of the ventricular response. Con-
sistent with this explanation is the observation that
exogenous catecholamines shorten the accessory
AV connection effective refractory period and in-
crease the ventricular rate during atrial fibrillation
in patients with the WPW syndrome.^"^ Svinarich
et al. demonstrated that the effects of isoproterenol
on accessory AV connection effective refractory
period during sinus rhythm are reversed by intra-
venous propranolol.^ Beta blockade might there-
fore also reverse the effects of adrenergic activation
and slow the ventricular response during atrial fi-
brillation. The ahsence of excess adrenergic acti-
vation during sinus rhythm may explain why no
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effects of propranolol on conduction or refracto-
riness were demonstrated either in this study or
in the study of Denes et al.^
Of note is that the ventricular rate during
atrial fibrillation accelerated markedly from 203
to 267 heats/min in one patient. This patient dif-
fered from the other patients in that more than
half of the QRS complexes during atrial fihrillation
were not preexcited, and the minimum R-R in-
terval hetween narrow QRS complexes (260 ms)
and also between preexcited QRS complexes (170
ms) was quite short. After propranolol, only 1% of
QRS complexes were narrow. By depressing con-
duction in the AV node, propranolol may have
eliminated retrograde concealed conduction in the
accessory AV connection, resulting in acceleration
of the ventricular rate.
This mechanism has also been postulated to
occur in response to intravenous verapamil in pa-
tients with the WPW syndrome who have both
narrow and preexcited QRS complexes during
atrial fibrillation.^ However, in contrast to pro-
pranolol, intravenous verapamil also results in an
acceleration of the ventricular rate during atrial
fibrillation even when most QRS complexes during
atrial fibrillation are preexcited.^ This has been
explained by intravenous verapamil's peripheral
vasodilating effect, which causes a fall in blood
pressure and a reflex increase in adrenergic tone.
Although intravenous propranolol was associated
with 5-10 mmHg drop in blood pressure in the
patients in this study, beta blockade presumably
prevented the acceleration in conduction through
the accessory AV connection which may have
otherwise occurred with a refiex increase in ad-
renergic tone.
A limitation of this study is that serial plasma
propranolol concentrations were not measured
and therefore it is not known whether a steady-
state plasma propranolol concentration was pres-
ent during the observation period.
In conclusion, despite the ahsence of direct
effects on accessory AV connection properties
during sinus rhythm, propranolol may slow the
ventricular response during atrial fibrillation in
patients with the WPW syndrome, probably by re-
versing the effects on the accessory AV connection
of adrenergic activation. The results of this study
suggest that propranolol can be used safely in pa-
tients with the WPW syndrome who have episodes
of atrial fibrillation, but only if most QRS com-
plexes during atrial fibrillation are preexcited. If
a large percentage of QRS complexes during atrial
fibrillation are narrow, propranolol may result in
a marked acceleration in the ventricular rate,
probably by eliminating concealed retrograde
conduction in the accessory AV connection.
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